New $90M Medtech Convergence Fund Will Focus On Home Technologies
SV Health Investors has launched a new $90m venture fund to develop early-stage medtech start-ups. The fund has received investment from Japanese technology group Tejin.
You may also be interested in...
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.